CompletedPhase 4NCT03776851

Erythropoietin in Hemolytic Uremic Syndrome

Studying Hemolytic uremic syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Hospital General de Niños Pedro de Elizalde
Principal Investigator: Alejandro Balestracci, MD, PhD
Hospital General de Niños Pedro de Elizalde
Intervention: erythropoietin(drug)
Enrollment: 24 target
Eligibility: 18 years · All sexes
Timeline: 2019 – 2020

Study locations (1)

HGNPE, CABA, Argentina

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03776851 on ClinicalTrials.gov

Other trials for Hemolytic uremic syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT06389474
Efficacy of INM004 in Children With STEC-HUS
Inmunova S.A.
RECRUITINGNANCT05219110
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
University of Calgary

See all trials for Hemolytic uremic syndrome →

← Back to all trials